Phase II Trial of Sunitinib in Patients With Metastatic Colorectal Cancer After Failure of Standard Therapy
J Clin Oncol Saltz et al. 25:4793
Publisher’s Note
The October 20, 2007, article by Saltz et al entitled, “Phase II Trial of Sunitinib in Patients With Metastatic Colorectal Cancer After Failure of Standard Therapy” (J Clin Oncol 25:4793-4799, 2007) was published online October 18, 2007 with errors.
In Figure 1, the response data were inadvertently mislabeled. In Figure 2A, the median time to tumor progression for the prior bevacizumab cohort was given as 2.5 months, whereas it should have been 2.2 months.
All corrections have been made as of December 13, 2007.
|
